These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 18832576)

  • 21. Muscular dystrophy with marked Dysferlin deficiency is consistently caused by primary dysferlin gene mutations.
    Cacciottolo M; Numitone G; Aurino S; Caserta IR; Fanin M; Politano L; Minetti C; Ricci E; Piluso G; Angelini C; Nigro V
    Eur J Hum Genet; 2011 Sep; 19(9):974-80. PubMed ID: 21522182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Late onset in dysferlinopathy widens the clinical spectrum.
    Klinge L; Dean AF; Kress W; Dixon P; Charlton R; Müller JS; Anderson LV; Straub V; Barresi R; Lochmüller H; Bushby K
    Neuromuscul Disord; 2008 Apr; 18(4):288-90. PubMed ID: 18396043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Membrane repair of human skeletal muscle cells requires Annexin-A5.
    Carmeille R; Bouvet F; Tan S; Croissant C; Gounou C; Mamchaoui K; Mouly V; Brisson AR; Bouter A
    Biochim Biophys Acta; 2016 Sep; 1863(9):2267-79. PubMed ID: 27286750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysferlin function in skeletal muscle: Possible pathological mechanisms and therapeutical targets in dysferlinopathies.
    Cárdenas AM; González-Jamett AM; Cea LA; Bevilacqua JA; Caviedes P
    Exp Neurol; 2016 Sep; 283(Pt A):246-54. PubMed ID: 27349407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ahnak1 abnormally localizes in muscular dystrophies and contributes to muscle vesicle release.
    Zacharias U; Purfürst B; Schöwel V; Morano I; Spuler S; Haase H
    J Muscle Res Cell Motil; 2011 Dec; 32(4-5):271-80. PubMed ID: 22057634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 4th Annual Dysferlin Conference 11-14 September 2010, Washington, USA.
    Albrecht DE; Garg N; Rufibach LE; Williams BA; Monnier N; Hwang E; Mittal P
    Neuromuscul Disord; 2011 Apr; 21(4):304-10. PubMed ID: 21339068
    [No Abstract]   [Full Text] [Related]  

  • 27. Symptomatic dysferlin gene mutation carriers: characterization of two cases.
    Illa I; De Luna N; Domínguez-Perles R; Rojas-García R; Paradas C; Palmer J; Márquez C; Gallano P; Gallardo E
    Neurology; 2007 Apr; 68(16):1284-9. PubMed ID: 17287450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracellular accumulation and reduced sarcolemmal expression of dysferlin in limb--girdle muscular dystrophies.
    Piccolo F; Moore SA; Ford GC; Campbell KP
    Ann Neurol; 2000 Dec; 48(6):902-12. PubMed ID: 11117547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression profiling with progression of dystrophic change in dysferlin-deficient mice (SJL).
    Suzuki N; Aoki M; Hinuma Y; Takahashi T; Onodera Y; Ishigaki A; Kato M; Warita H; Tateyama M; Itoyama Y
    Neurosci Res; 2005 May; 52(1):47-60. PubMed ID: 15811552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Muscle protein analysis in the detection of heterozygotes for recessive limb girdle muscular dystrophy type 2B and 2E.
    Fanin M; Nascimbeni AC; Angelini C
    Neuromuscul Disord; 2006 Nov; 16(11):792-9. PubMed ID: 16934466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency.
    Ho M; Post CM; Donahue LR; Lidov HG; Bronson RT; Goolsby H; Watkins SC; Cox GA; Brown RH
    Hum Mol Genet; 2004 Sep; 13(18):1999-2010. PubMed ID: 15254015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defective membrane repair in dysferlin-deficient muscular dystrophy.
    Bansal D; Miyake K; Vogel SS; Groh S; Chen CC; Williamson R; McNeil PL; Campbell KP
    Nature; 2003 May; 423(6936):168-72. PubMed ID: 12736685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Muscle inflammation, autoimmune Addison's disease and sarcoidosis in a patient with dysferlin deficiency.
    Selva-O'Callaghan A; Labrador-Horrillo M; Gallardo E; Herruzo A; Grau-Junyent JM; Vilardell-Tarres M
    Neuromuscul Disord; 2006 Mar; 16(3):208-9. PubMed ID: 16483775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel sequence variants in dysferlin-deficient muscular dystrophy leading to mRNA decay and possible C2-domain misfolding.
    Wenzel K; Carl M; Perrot A; Zabojszcza J; Assadi M; Ebeling M; Geier C; Robinson PN; Kress W; Osterziel KJ; Spuler S
    Hum Mutat; 2006 Jun; 27(6):599-600. PubMed ID: 16705711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dysferlin aggregation in limb-girdle muscular dystrophy type 2B/Miyoshi Myopathy necessitates mutational screen for diagnosis [corrected].
    Nilsson MI; Laureano ML; Saeed M; Tarnopolsky MA
    Muscle Nerve; 2013 May; 47(5):740-7. PubMed ID: 23519732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pattern of skeletal muscle involvement in primary dysferlinopathies: a whole-body 3.0-T magnetic resonance imaging study.
    Kesper K; Kornblum C; Reimann J; Lutterbey G; Schröder R; Wattjes MP
    Acta Neurol Scand; 2009 Aug; 120(2):111-8. PubMed ID: 19154541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dysferlin mutation analysis in a group of Italian patients with limb-girdle muscular dystrophy and Miyoshi myopathy.
    Kawabe K; Goto K; Nishino I; Angelini C; Hayashi YK
    Eur J Neurol; 2004 Oct; 11(10):657-61. PubMed ID: 15469449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of correlation between outcomes of membrane repair assay and correction of dystrophic changes in experimental therapeutic strategy in dysferlinopathy.
    Lostal W; Bartoli M; Roudaut C; Bourg N; Krahn M; Pryadkina M; Borel P; Suel L; Roche JA; Stockholm D; Bloch RJ; Levy N; Bashir R; Richard I
    PLoS One; 2012; 7(5):e38036. PubMed ID: 22666441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysferlin associates with the developing T-tubule system in rodent and human skeletal muscle.
    Klinge L; Harris J; Sewry C; Charlton R; Anderson L; Laval S; Chiu YH; Hornsey M; Straub V; Barresi R; Lochmüller H; Bushby K
    Muscle Nerve; 2010 Feb; 41(2):166-73. PubMed ID: 20082313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutation finding in patients with dysferlin deficiency and role of the dysferlin interacting proteins annexin A1 and A2 in muscular dystrophies.
    Cagliani R; Magri F; Toscano A; Merlini L; Fortunato F; Lamperti C; Rodolico C; Prelle A; Sironi M; Aguennouz M; Ciscato P; Uncini A; Moggio M; Bresolin N; Comi GP
    Hum Mutat; 2005 Sep; 26(3):283. PubMed ID: 16100712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.